Annual Net Income
-$41.24 M
+$8.62 M+17.29%
01 June 2022
Summary:
Pluristem Therapeutics annual net profit is currently -$41.24 million, with the most recent change of +$8.62 million (+17.29%) on 01 June 2022. During the last 3 years, it has risen by +$8.62 million (+17.29%).PSTI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$6.12 M
+$2.88 M+32.03%
01 September 2022
Summary:
Pluristem Therapeutics quarterly net profit is currently -$6.12 million, with the most recent change of +$2.88 million (+32.03%) on 01 September 2022.PSTI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$35.93 M
+$5.31 M+12.88%
01 September 2022
Summary:
Pluristem Therapeutics TTM net profit is currently -$35.93 million, with the most recent change of +$5.31 million (+12.88%) on 01 September 2022.PSTI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +17.3% | +46.5% | +32.0% |
| 5 y5 years | -16.8% | +14.3% | -6.8% |
PSTI Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | >+9999.0% | <-9999.0% | >+9999.0% |
Pluristem Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$6.12 M(-32.0%) | -$35.93 M(-12.9%) |
| June 2022 | -$41.24 M(-17.3%) | -$9.01 M(-8.7%) | -$41.24 M(-11.9%) |
| Mar 2022 | - | -$9.87 M(-9.8%) | -$46.80 M(-8.6%) |
| Dec 2021 | - | -$10.94 M(-4.3%) | -$51.19 M(-3.1%) |
| Sept 2021 | - | -$11.43 M(-21.5%) | -$52.81 M(+5.9%) |
| June 2021 | -$49.87 M(+71.1%) | -$14.57 M(+2.2%) | -$49.87 M(+14.8%) |
| Mar 2021 | - | -$14.25 M(+13.5%) | -$43.43 M(+18.4%) |
| Dec 2020 | - | -$12.55 M(+47.9%) | -$36.69 M(+20.3%) |
| Sept 2020 | - | -$8.49 M(+4.3%) | -$30.50 M(+4.6%) |
| June 2020 | -$29.15 M(-17.4%) | -$8.14 M(+8.4%) | -$29.15 M(+1.3%) |
| Mar 2020 | - | -$7.51 M(+17.8%) | -$28.78 M(-8.2%) |
| Dec 2019 | - | -$6.37 M(-10.8%) | -$31.35 M(-6.9%) |
| Sept 2019 | - | -$7.14 M(-8.0%) | -$33.66 M(-4.7%) |
| June 2019 | -$35.31 M(+35.1%) | -$7.76 M(-23.0%) | -$35.31 M(-3.3%) |
| Mar 2019 | - | -$10.08 M(+16.1%) | -$36.53 M(+30.5%) |
| Dec 2018 | - | -$8.68 M(-1.2%) | -$27.98 M(+1.6%) |
| Sept 2018 | - | -$8.79 M(-2.2%) | -$27.53 M(+5.4%) |
| June 2018 | -$26.13 M(-6.1%) | -$8.98 M(+486.6%) | -$26.13 M(+8.1%) |
| Mar 2018 | - | -$1.53 M(-81.4%) | -$24.16 M(-20.8%) |
| Dec 2017 | - | -$8.23 M(+11.4%) | -$30.49 M(+5.6%) |
| Sept 2017 | - | -$7.38 M(+5.3%) | -$28.88 M(+3.8%) |
| June 2017 | -$27.81 M(+19.7%) | -$7.02 M(-10.8%) | -$27.81 M(+3.0%) |
| Mar 2017 | - | -$7.86 M(+19.0%) | -$27.00 M(+2.5%) |
| Dec 2016 | - | -$6.61 M(+4.5%) | -$26.34 M(+11.2%) |
| Sept 2016 | - | -$6.32 M(+1.9%) | -$23.69 M(+1.9%) |
| June 2016 | -$23.25 M(-5.8%) | -$6.21 M(-13.9%) | -$23.25 M(+4.1%) |
| Mar 2016 | - | -$7.20 M(+81.8%) | -$22.34 M(-0.1%) |
| Dec 2015 | - | -$3.96 M(-32.6%) | -$22.36 M(-9.3%) |
| Sept 2015 | - | -$5.88 M(+11.0%) | -$24.64 M(-0.1%) |
| June 2015 | -$24.68 M(-8.4%) | -$5.29 M(-26.7%) | -$24.68 M(-3.5%) |
| Mar 2015 | - | -$7.23 M(+15.7%) | -$25.58 M(-7.4%) |
| Dec 2014 | - | -$6.25 M(+5.7%) | -$27.63 M(-1.6%) |
| Sept 2014 | - | -$5.91 M(-4.6%) | -$28.09 M(+4.3%) |
| June 2014 | -$26.93 M(+27.3%) | -$6.20 M(-33.2%) | -$26.93 M(-2.9%) |
| Mar 2014 | - | -$9.28 M(+38.3%) | -$27.73 M(+14.9%) |
| Dec 2013 | - | -$6.71 M(+41.0%) | -$24.13 M(+10.1%) |
| Sept 2013 | - | -$4.75 M(-32.0%) | -$21.91 M(+3.6%) |
| June 2013 | -$21.16 M(+43.0%) | -$6.99 M(+23.1%) | -$21.16 M(+15.6%) |
| Mar 2013 | - | -$5.68 M(+26.5%) | -$18.30 M(+9.0%) |
| Dec 2012 | - | -$4.49 M(+12.4%) | -$16.79 M(+17.5%) |
| Sept 2012 | - | -$4.00 M(-3.4%) | -$14.30 M(-3.4%) |
| June 2012 | -$14.79 M | -$4.13 M(-0.9%) | -$14.79 M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$4.17 M(+109.5%) | -$14.38 M(+12.2%) |
| Dec 2011 | - | -$1.99 M(-55.7%) | -$12.82 M(-6.1%) |
| Sept 2011 | - | -$4.49 M(+20.6%) | -$13.65 M(+25.8%) |
| June 2011 | -$10.85 M(+45.6%) | -$3.73 M(+42.6%) | -$10.85 M(+22.4%) |
| Mar 2011 | - | -$2.61 M(-7.4%) | -$8.87 M(+4.1%) |
| Dec 2010 | - | -$2.82 M(+67.0%) | -$8.52 M(+13.2%) |
| Sept 2010 | - | -$1.69 M(-3.0%) | -$7.53 M(+1.0%) |
| June 2010 | -$7.45 M(+12.3%) | -$1.74 M(-23.0%) | -$7.45 M(+2.4%) |
| Mar 2010 | - | -$2.26 M(+23.6%) | -$7.28 M(+3.8%) |
| Dec 2009 | - | -$1.83 M(+13.2%) | -$7.01 M(+16.6%) |
| Sept 2009 | - | -$1.62 M(+3.2%) | -$6.01 M(-9.4%) |
| June 2009 | -$6.64 M(-36.8%) | -$1.57 M(-21.4%) | -$6.64 M(-18.5%) |
| Mar 2009 | - | -$1.99 M(+139.4%) | -$8.14 M(-7.1%) |
| Dec 2008 | - | -$833.00 K(-62.8%) | -$8.76 M(-16.2%) |
| Sept 2008 | - | -$2.24 M(-27.0%) | -$10.46 M(-0.4%) |
| June 2008 | -$10.50 M(+24.5%) | -$3.07 M(+17.3%) | -$10.50 M(-4.3%) |
| Mar 2008 | - | -$2.62 M(+3.5%) | -$10.97 M(-10.6%) |
| Dec 2007 | - | -$2.53 M(+11.0%) | -$12.27 M(+17.7%) |
| Sept 2007 | - | -$2.28 M(-35.6%) | -$10.42 M(+23.7%) |
| June 2007 | -$8.43 M(+245.5%) | -$3.54 M(-9.8%) | -$8.43 M(+44.4%) |
| Mar 2007 | - | -$3.92 M(+475.2%) | -$5.84 M(+129.5%) |
| Dec 2006 | - | -$682.00 K(+140.1%) | -$2.54 M(+8.3%) |
| Sept 2006 | - | -$284.00 K(-70.1%) | -$2.35 M(-3.7%) |
| June 2006 | -$2.44 M(+16.3%) | -$950.00 K(+51.1%) | -$2.44 M(+67.5%) |
| Mar 2006 | - | -$628.60 K(+29.3%) | -$1.46 M(-35.3%) |
| Dec 2005 | - | -$486.00 K(+29.6%) | -$2.25 M(+3.9%) |
| Sept 2005 | - | -$375.10 K(-1240.1%) | -$2.17 M(+3.2%) |
| June 2005 | -$2.10 M(-70.4%) | $32.90 K(-102.3%) | -$2.10 M(-71.8%) |
| Mar 2005 | - | -$1.42 M(+253.8%) | -$7.43 M(+4.6%) |
| Dec 2004 | - | -$401.90 K(+30.9%) | -$7.11 M(+0.4%) |
| Sept 2004 | - | -$307.10 K(-94.2%) | -$7.07 M(-0.2%) |
| June 2004 | -$7.09 M(+1431.1%) | -$5.30 M(+382.2%) | -$7.09 M(+221.2%) |
| Mar 2004 | - | -$1.10 M(+196.4%) | -$2.21 M(+97.8%) |
| Dec 2003 | - | -$370.60 K(+14.9%) | -$1.12 M(+48.1%) |
| Sept 2003 | - | -$322.50 K(-22.4%) | -$753.50 K(+67.0%) |
| June 2003 | -$463.00 K(+494.4%) | -$415.80 K(+5926.1%) | -$451.30 K(+662.3%) |
| Mar 2003 | - | -$6900.00(-16.9%) | -$59.20 K(-18.6%) |
| Dec 2002 | - | -$8300.00(-59.1%) | -$72.70 K(-12.3%) |
| Sept 2002 | - | -$20.30 K(-14.3%) | -$82.90 K(+32.4%) |
| June 2002 | -$77.90 K | -$23.70 K(+16.2%) | -$62.60 K(+60.9%) |
| Mar 2002 | - | -$20.40 K(+10.3%) | -$38.90 K(+110.3%) |
| Dec 2001 | - | -$18.50 K | -$18.50 K |
FAQ
- What is Pluristem Therapeutics annual net profit?
- What is the all time high annual net income for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Pluristem Therapeutics?
- What is Pluristem Therapeutics TTM net profit?
- What is the all time high TTM net income for Pluristem Therapeutics?
What is Pluristem Therapeutics annual net profit?
The current annual net income of PSTI is -$41.24 M
What is the all time high annual net income for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual net profit is -$77.90 K
What is Pluristem Therapeutics quarterly net profit?
The current quarterly net income of PSTI is -$6.12 M
What is the all time high quarterly net income for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly net profit is $32.90 K
What is Pluristem Therapeutics TTM net profit?
The current TTM net income of PSTI is -$35.93 M
What is the all time high TTM net income for Pluristem Therapeutics?
Pluristem Therapeutics all-time high TTM net profit is -$18.50 K